Laboratorios Farmaceuticos Rovi

Patent cliffs & loss of exclusivity

Biosimilars, Contract Manufacturing, Licensed Products

Company

LinkedIn URLhttps://www.linkedin.com/company/pharmaceutical-laboratories-rovi/
Official Websitehttp://rovi.com

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. RISVANRISPERIDONESmall mol.May 2031
  2. RISVANRISPERIDONESmall mol.May 2031

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.